Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by high throughput sequencing | Homo sapiens | TXT | Mar 04, 2024 | ||||
GSE164455 |
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [RNA-seq]
|
|
33 |
|
Hongjian Jin | Mar 04, 2024 | ||
GSE197569 |
Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors
|
|
31 |
|
Kirsi Rautajoki | Mar 04, 2024 | ||
GSE207013 |
RNA-seq of KDM4A, B and C siRNA knockdown in NB cells
|
|
24 | Hongjian Jin | Mar 04, 2024 | |||
GSE222264 |
Phase separation-competent FBL shapes nucleolar function and translation in leukemogenesis (RNA-Seq)
|
|
8 | Jiang Penglei | Mar 04, 2024 | |||
GSE222266 |
Phase separation-competent FBL shapes nucleolar function and translation in leukemogenesis
|
|
14 |
|
Jiang Penglei | Mar 04, 2024 | ||
GSE228839 |
COVID-19 vaccination is associated with attenuation of inflammatory responses during breakthrough disease [Illumina RNA-Seq]
|
|
180 | Irina Chelysheva | Mar 04, 2024 | |||
GSE228840 |
COVID-19 vaccination is associated with attenuation of inflammatory responses during breakthrough disease [long-read RNA-Seq]
|
|
39 | Irina Chelysheva | Mar 04, 2024 | |||
GSE241679 |
Systematic identification and characterization of Exon-intron circRNAs (RNA-Seq)
|
|
26 | Yan Yang | Mar 04, 2024 | |||
GSE246045 |
Chromatin accessibility and transcriptomic responses to HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids [RNA-seq]
|
|
18 | Emanuela Kerschbamer | Mar 04, 2024 | |||
GSE253769 |
Autophagy-enhancing ATG16L1 polymorphism improves clinical outcomes and promotes superior T-cell immunity in chronic HIV-1 infection
|
|
32 | Carla Ribeiro | Mar 04, 2024 | |||
GSE260487 |
The differential gene screening for invasive pituitary adenoma and non-invasive pituitary adenoma
|
|
32 | Yu Zhang | Mar 04, 2024 | |||
GSE260597 |
Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors (human)
|
|
6 | Lee Benjamin Rivera | Mar 04, 2024 | |||
GSE260598 |
Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors (GeoMx)
|
|
48 |
|
Lee Benjamin Rivera | Mar 04, 2024 |